Loading data for EMBC — first visit, this takes a few seconds.

Alerta

Embecta Corp. (EMBC)

NasdaqGS: EMBC · Precio en tiempo real · USD

5.42

+0.32 (6.27%)

Al cierre: Aug 19, 2026, 8:00 PM

5.40

-0.37%

Fuera de horario: 6:05 PM

6.27% (1D)

No hay datos disponibles

Precio de compra	n/a
Capitalización de mercado	307.1M
Ingresos (TTM)	1.02B
Beneficio neto (TTM)	87.5M
Beta	0.79
EPS (TTM)	1.47
Ratio PER (TTM)	3.69
Adelante PE	3.08
P/B (TTM)	-0.50
P/S (TTM)	0.30
Earnings Date	Nov 25, 2026

Precio de venta	n/a
Volumen	1,256,820
Volumen medio (20D)	1,949,295
Abierto	5.10
Anterior Cerrar	5.10
Rango del día	5.10 - 5.43
Rango de 52 semanas	2.77 - 15.55
analista	n/a
Precio objetivo	n/a
Dividendos	$0.04 (0.78%)
Fecha ex dividendo	27 ago 2026

Acerca de EMBC

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, In...

[Leer más]

Industria Medical Instruments & Supplies

Sector Healthcare

IPO Fecha Mar 22, 2022

Empleados 1,850

Bolsa de Valores NasdaqGS

Símbolo bursátil EMBC

Sitio web https://www.embecta.com

Perfil completo de la empresa

Desempeño financiero

En 2025, los ingresos de Embecta fueron 1.08B, una disminución de -3.8% en comparación con 1.12B del año anterior. Las ganancias fueron 95.4M, un aumento de 21.84%.

Estados financieros

Sorpresa de resultados

Embecta ha publicado sus resultados trimestrales en Aug 7, 2026:

Ingresos de $271.7M falla las estimaciones por $0, con -8.05% Disminución interanual.

EPS de 0.56 supera las estimaciones en 0.29, con -50.00% Disminución interanual.

Próxima publicación de resultados

Está previsto que Embecta Corp. publique sus resultados el Nov 25, 2026, antes de que se abra el mercado.
Los analistas proyectan ingresos de ... Actualizar

Noticias

5 días hace · Motley Fool

Embecta (EMBC) Q3 2026 Earnings Call Transcript

Revenue fell 8.1% year-over-year, but margin guidance rose for fiscal 2026.

1 semana hace · Moby

Embecta Corp. Q3 2026 Earnings Call Summary

Moby summary of Embecta Corp.'s Q3 2026 earnings call

1 semana hace · GuruFocus.com

Embecta Corp (EMBC) (Q3 2026) Earnings Call Highlights: Strong Sequential Recovery and Raised ...

Embecta Corp (EMBC) beats expectations with a $50 million sequential revenue jump, raises adjusted EPS guidance, and advances its Owen Mumford integration despite persistent U.S. market pressures.

1 semana hace · MarketBeat

Embecta Q3 Earnings Call Highlights

Embecta (NASDAQ:EMBC) reported fiscal third-quarter 2026 revenue of approximately $272 million, down 8.1% from the prior-year period on a reported basis and down 8.9% on an adjusted constant-currency ...

1 mes hace · Simply Wall St.

Embecta (EMBC) Stock Fair Value Moves Lower As Analysts Reset Medtech Expectations

Embecta is in focus after one fair value estimate was reset from US$15.00 to US$4.00, which highlights how much some analysts have reworked their view of what the stock might be worth under updated as...

Página 1 de 2

Embecta Corp. (EMBC)